Processa Pharmaceuticals (PCSA) EPS (Basic) (2012 - 2026)
Processa Pharmaceuticals' (PCSA) quarterly EPS (Basic) came in at -$1.29 in Q1 2026, up 82.69% YoY from -$0.7 in Q1 2025, and up 49.82% on a QoQ basis from -$2.57 in Q4 2025.
Processa Pharmaceuticals (PCSA) EPS (Basic) (2012 - 2026) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 15 years of EPS (Basic) data on file, last reported at -$1.29 in Q1 2026.
- Quarterly EPS (Basic) rose 82.69% year-over-year to -$1.29 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.38 (up 82.86% YoY) and the FY2025 annual result came in at -$10.36, up 89.3% from the prior year.
- EPS (Basic) improved to -$1.29 in Q1 2026, from -$2.57 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$1.29 in Q1 2026 to a low of -$403.87 in Q4 2022.
- A 5-year average of -$70.31 and a median of -$27.63 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) sank 288.66% — and 2025, when it jumped 93.0%.
- Tracing PCSA's EPS (Basic) over 5 years: stood at -$403.87 in 2022, then soared by 88.65% to -$45.84 in 2023, then soared by 51.37% to -$22.29 in 2024, then soared by 88.49% to -$2.57 in 2025, then surged by 49.82% to -$1.29 in 2026.
- The last three EPS (Basic) figures came in at -$1.29 (Q1 2026), -$2.57 (Q4 2025), and -$1.81 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Processa Pharmaceuticals | 5.69 Mn | 5.69 Mn | - | -1.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29 |
| Dec 31, 2025 | -2.57 |
| Sep 30, 2025 | -1.81 |
| Jun 30, 2025 | -6.32 |
| Mar 31, 2025 | -7.44 |
| Dec 31, 2024 | -22.29 |
| Sep 30, 2024 | -25.83 |
| Jun 30, 2024 | -25.23 |
| Mar 31, 2024 | -27.63 |
| Dec 31, 2023 | -45.84 |
| Sep 30, 2023 | -38.55 |
| Jun 30, 2023 | -48.50 |
| Mar 31, 2023 | -88.32 |
| Dec 31, 2022 | -403.87 |
| Sep 30, 2022 | -185.82 |
| Jun 30, 2022 | -161.99 |
| Mar 31, 2022 | -101.92 |
| Dec 31, 2021 | -103.91 |
| Sep 30, 2021 | -96.17 |
| Jun 30, 2021 | -102.46 |